Technopolis Moscow Resident Designs Cardiac Pump

Zelenograd Innovation and Technology Center (ZITC), a resident of the Technopolis Moscow special economic zone, has designed Sputnik-D, Russia's first implantable blood pump for children.
 



The pump is a smaller version of AVK-N Sputnik, a ventricular assist device (VAD) that has been successfully used in Russia for the treatment of heart failure since 2012. Sputnik-D will be possible to implant even in infants. The groundbreaking development in pediatric cardiac surgery will significantly increase survival chances for children with acute heart failure.

“We see that the measures of the Moscow government to support innovative producers bring results.  Zelenograd Innovation and Technology Center receives a number of tax preferences. In particular, the organization is exempt from regional income, property, land and transport taxes. All this allows the company to invest in its business development. Since 2006, when ZITC joined Technopolis Moscow, we've built 25 thousand square meters of properties for innovation,” said Moscow Deputy Mayor Vladimir Efimov.

“Solutions designed by Moscow companies help the Russian medicine confidently move forward. Currently, about 20 companies engaged in medical equipment and biopharmaceutics research and manufacturing operate at Technopolis Moscow. They make products that help save lives – from artificial skin to cancer treatment drugs,” said Alexander Prokhorov, head of the Department of Investment and Industrial Policy.

The project to develop a ventricular assist system for children started in 2015 at the Department of Biomedical Systems of the National Research University MIET with participation from scientists of the Zelenograd Innovation and Technology Center.

The miniaturization of assist systems reduces the invasiveness of the implantation procedure and expands the possibilities of VAD for patients with body sizes smaller than in people with a height of 160 cm and a mass of 50 kg (for patients with a body surface area of less than 1.5 square meters).

The development cycle of the new device has been completed. Now the system is undergoing a registration process.

“Every year about 250 donor hearts are transplanted in Russia. This figure is negligible compared to how many people need heart transplantation today. Ventricular assist systems are designed to support blood flow in people with weakened hearts. Survival of patients with VADs reaches 70% within the first two years after implantation,” said Sergey Portnov, director of ZITC.

18 april 2019